Indian pharma players

Indian pharma companies have one critical opportunity they can tap – that of research outsourcing. States Sanjay Aggarwal, Pharmaceutical Sector Leader, KPMG India, “Most (Indian pharma players) will be unable to develop the financial muscle necessary to embark on R&D for innovative new products, but their scientific, technical & manufacturing skills perfectly match the requirements of global drug manufacturers that are increasingly seeking to off shore many research and manufacturing activities.” An instance is the recent Ranbaxy-GSK tie-up for drug research. By leveraging on their low-cost base, Indian companies can overcome constraints of high R&D spends. Just think about it, Ranbaxy & Pfi zer could actually combine to create a new ‘Lipitor’...

For complete IIPM article click here

Source:- IIPM Editorial

Visit also:- IIPM Publication, Business & Economy & Arindam Chaudhuri Initiative